News Daily News Patients With A-fib Still Have High Mortality Risk After Appropriate Anticoagulation Is Started Todd Neale December 05, 2016
News Conference News AHA 2016 Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention Yael L. Maxwell November 29, 2016
News Conference News AHA 2016 Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results Todd Neale November 15, 2016
News Conference News AHA 2016 No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION Shelley Wood November 13, 2016
News Daily News Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows Michael O'Riordan September 30, 2016
News Daily News Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice Michael O'Riordan September 16, 2016
News Conference News ESC 2016 Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER Michael O'Riordan August 30, 2016
News Daily News Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings Michael O'Riordan July 12, 2016
News Daily News Aspirin App Pairs Clinical Studies With Technology to Balance Bleeding, Benefits Michael H. Wilson June 27, 2016
News Daily News USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals Michael O'Riordan April 12, 2016
News Daily News New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin Caitlin E. Cox March 23, 2016
News Daily News ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy April 29, 2015
News Daily News Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients Caitlin E. Cox April 19, 2013